President's Message

Stephen F. Miller named the society's next executive director

Toni M. Antalis
Jan. 22, 2021

On behalf of the American Society for Biochemistry and Molecular Biology Council, I am pleased to announce that Stephen F. Miller, deputy executive director and chief financial officer of the ASBMB, will be appointed to the position of executive director upon the retirement of the current executive director, Barbara Gordon.

Anand Rao
Stephen F. Miller has been the ASBMB's deputy executive director and chief financial officer.

Stephen joined the society in July 2004 as the financial controller. During the succeeding years of his service to the society, he held the positions of director of finance and then chief financial officer. He has become more involved in the journals and society operations as  deputy executive director.

The ASBMB Council began the process of identifying a new executive director upon the announcement of Barbara’s retirement. With the major move of our journals to open access, as well as other anticipated operational enhancements, the Council considered the importance of continuity and experience with society operations to be critically important during this transition period. Based on Stephen’s deep knowledge of and commitment to the society, the Council made the decision to ask him to take on the role of executive director, and we are delighted that he has agreed to serve in this position for the next several years. In early 2023, the ASBMB Council plans to initiate a wide-ranging search for the next, longer-term executive director. This plan will allow for an orderly transition of the society leadership and move to open access.

In his new capacity as executive director, Stephen will be shepherding the transition to open access for the ASBMB journals, developing a strategic plan to guide the society through the next several years and expanding the opportunities and benefits the society provides for its members.

We warmly thank Barbara for her many years of service and for her long-lasting legacy in bringing the society to where it is today. We are also deeply thankful for the commitment and dedication of all of the ASBMB staff during this time of transition as we open an exciting new chapter for the society.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Toni M. Antalis

Toni Antalis is a professor of physiology at the University of Maryland School of Medicine, where she is also the associate director for training and education for the Greenebaum Cancer Center and the director of the graduate program in molecular medicine. She began her term as the ASBMB’s president in July 2020.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Alan G. Goodridge
In Memoriam

In memoriam: Alan G. Goodridge

Dec. 9, 2025

He made pioneering discoveries on lipid metabolism and was an ASBMB member since 1971.

Alrubaye wins research and teaching awards
Member News

Alrubaye wins research and teaching awards

Dec. 8, 2025

He was honored at the NACTA 2025 conference for the Educator Award and at the U of A State and National Awards reception for the Faculty Gold Medal.

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Jordahl named Gilliam Fellow
Member News

Jordahl named Gilliam Fellow

Dec. 1, 2025

He will receive three years of funding to support his thesis research.

Bibel named assistant professor
Member News

Bibel named assistant professor

Nov. 24, 2025

She began her position at Loyola Marymount University in August 2025.

Unraveling the language of histones
Profile

Unraveling the language of histones

Nov. 20, 2025

Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.